The Greek director of the positron emission tomography (PET/CT) scanner at the DFKZ research centre in Heidelberg talks about ...
The radiopharmaceutical lutetium 177 can be used after radium 223 to treat metastatic castration-resistant prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback